Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AIM ImmunoTech Inc. Common Stock
(NY:
AIM
)
0.1900
-0.0011 (-0.58%)
Official Closing Price
Updated: 8:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
344,242
Open
0.1892
Bid (Size)
0.1910 (11)
Ask (Size)
0.2000 (1)
Prev. Close
0.1911
Today's Range
0.1852 - 0.1990
52wk Range
0.1628 - 0.6200
Shares Outstanding
4,020,334
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting
December 17, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card
December 16, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Performance
YTD
-60.00%
-60.00%
1 Month
-9.57%
-9.57%
3 Month
-24.81%
-24.81%
6 Month
-51.41%
-51.41%
1 Year
-62.37%
-62.37%
More News
Read More
AIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board Members
December 12, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Glass Lewis Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan, Thomas K. Equels and Dr. William M. Mitchell
December 10, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Insights into AIM ImmunoTech's Upcoming Earnings
November 14, 2024
Via
Benzinga
Exploring AIM ImmunoTech's Earnings Expectations
November 07, 2024
Via
Benzinga
AIM Stock Earnings: AIM ImmunoTech Misses EPS for Q1 2024
May 16, 2024
Via
InvestorPlace
ISS Recommends AIM ImmunoTech Shareholders Vote “FOR” Company Nominees Nancy K. Bryan and Dr. William M. Mitchell
December 05, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Issues Presentation Detailing Why Shareholders Should NOT Elect Activist Group’s Nominees to the Board
December 02, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Refutes Activist Group’s False and Misleading Claims
November 27, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
AIM ImmunoTech Announces Cash Conservation Plan
November 27, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Preview: AIM ImmunoTech's Earnings
April 01, 2024
Via
Benzinga
AIM ImmunoTech Issues Presentation Detailing Case for Re-Electing Current Directors to Oversee Continued Momentum and Drive Strategy to Create Long-Term Value for Patients and Shareholders
November 25, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
Earnings Scheduled For November 15, 2024
November 15, 2024
Via
Benzinga
AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
November 04, 2024
From
AIM ImmunoTech Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 03, 2024
Via
Benzinga
AIM Stock Earnings: AIM ImmunoTech Beats EPS, Beats Revenue for Q2 2024
August 15, 2024
Via
InvestorPlace
AIM Stock Earnings: AIM ImmunoTech Misses EPS, Beats Revenue for Q4 2023
April 02, 2024
Via
InvestorPlace
Earnings Scheduled For April 2, 2024
April 02, 2024
Via
Benzinga
AIM ImmunoTech And 3 Other Stocks Under $3 Insiders Are Buying
March 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
February 12, 2024
Via
Benzinga
Earnings Scheduled For March 26, 2024
March 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 11, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 09, 2024
Via
InvestorPlace
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.